Gregory P Hanson's Net Worth
$143 Thousand
Who is Gregory P Hanson?
Gregory P Hanson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ADVENTRX PHARMACEUTICALS INC, AVANIR PHARMACEUTICALS, and MABVAX THERAPEUTICS HOLDINGS, INC..
SEC CIK
Gregory P Hanson's CIK is 0001186120
Past Insider Trading and Trends
2017 was Gregory P Hanson's most active year for acquiring shares with 7 total transactions. Gregory P Hanson's most active month to acquire stocks was the month of March. 2017 was Gregory P Hanson's most active year for disposing of shares, totalling 10 transactions. Gregory P Hanson's most active month to dispose stocks was the month of March. 2015 saw Gregory P Hanson paying a total of $1,075,480.00 for 935,200 shares, this is the most they've acquired in one year. In 2018 Gregory P Hanson cashed out on 616,960 shares for a total of $151,116.94, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ADVENTRX PHARMACEUTICALS INC (SVRA) Snapshot price: $4.42
Senior VP, CFO & Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANIR PHARMACEUTICALS No price found
VP, CAO & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +337.01% | 17.4K |
—
|
—
| 22.56K |
Dec 13
| |||
Form 4
| +27.07% | 1.1K |
$9.67 | $10,632.00 | 5.16K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
| No matching records found | |||||||||
MABVAX THERAPEUTICS HOLDINGS, INC. No price found
CHIEF FINANCIAL OFFICER, SECR
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.19% | 4.59K |
—
|
—
| 114.31K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -11.57% | -41.87K |
$0.92 | -$38,523.16 | 320.01K |
Jan 16
| |||
Form 4
| +1,139.08% | 332.68K |
$0.97 | -$112,593.78 | 361.89K |
Jan 8 - Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
| +31.25% | 9.13K |
$1.75 |
—
| 38.33K |
May 19
| |||
Form 4
| -11.74% | -3.88K |
$2.00 | -$7,770.39 | 29.21K |
Apr 12
| |||
Form 4
| -3.08% | -1.05K |
$2.00 | -$2,102.25 | 33.09K |
Apr 7 - Apr 11
| |||
Form 4
| -9.70% | -3.67K |
$2.18 | -$7,984.22 | 34.14K |
Apr 4 - Apr 6
| |||
Form 4
| +125.80% | 21.06K |
—
|
—
| 37.81K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
| +22.89% | 3.12K |
—
|
—
| 16.74K |
Aug 17
| |||
Form 4
| +3,260.77% | 97.82K |
—
|
—
| 100.82K |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
∞
| 3K |
$2.50 | $7,500.00 | 3K |
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||